Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
DYNC2LI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ARL4C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZC3H3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF319 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
QSER1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIK3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF701 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
IFFO2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLIC6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100133461 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AICDA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SUSD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TOR1AIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MC4R - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on